FDA Meeting Will Spotlight “Challenges” With Cannabis Compounds in Foods and Supplements

The meeting, which will use cannabinoids as a “case study” in assessing the “safety” of certain foods and supplements, comes as the FDA wrestles with rulemaking for CBD products.

Regulation
Congress, Newsletter

In Congress, Republicans Swing Against Cannabis Rescheduling

An excerpt from the Cannabis Wire Daily newsletter.

New York

Cannabis Loyalty Programs, Discounts Could Soon Come to New York’s Legal Shops

Regulators proposed new rules to open the door to billboards, discounts, and loyalty programs – which have already shown up at some shops.